Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price shot up 21.2% during trading on Friday . The company traded as high as C$0.21 and last traded at C$0.20. 292,294 shares changed hands during mid-day trading, a decline of 46% from the average session volume of 538,273 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Performance
The business’s 50 day simple moving average is C$0.10 and its two-hundred day simple moving average is C$0.07. The firm has a market capitalization of C$27.89 million, a PE ratio of -20.00 and a beta of 0.32. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
See Also
- Five stocks we like better than Voyageur Pharmaceuticals
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- What Investors Need to Know About Upcoming IPOs
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
